The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSuperdry Regulatory News (SDRY)

Share Price Information for Superdry (SDRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.40
Bid: 7.40
Ask: 7.45
Change: 0.66 (9.79%)
Spread: 0.05 (0.676%)
Open: 6.45
High: 7.50
Low: 6.45
Prev. Close: 6.74
SDRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.8 Announcement

28 Mar 2024 16:37

RNS Number : 7874I
Julian Marc Dunkerton
28 March 2024
 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

FOR IMMEDIATE RELEASE

 

28 March 2024

 

Statement Regarding Superdry plc

 

Following a period of engagement with the Transaction Committee (being the Company's Board of Directors excluding Julian Dunkerton) of Superdry plc ("Superdry" or the "Company"), Julian Dunkerton, Founder and Chief Executive Officer of Superdry, and the Transaction Committee have, together, concluded that a takeover offer from Julian Dunkerton for the Company is unlikely to deliver an outcome for shareholders, or stakeholders more broadly, that the Transaction Committee and Julian Dunkerton are confident can be executed in the context of the Company's ongoing work on its turnaround plan and material cost saving options.

However, Julian Dunkerton remains fully committed to the Company over the long-term and is in discussions with the Company in respect of alternative structures, including a possible equity raise fully underwritten by Julian Dunkerton, which would provide additional liquidity headroom for the Company's turnaround plan. It is expected that any equity raise would be at a very material discount to the current share price, require shareholder approval of a Rule 9 waiver (as referred in Note 1 of the Notes on Dispensations from Rule 9 of the Code) and be conditional on a de-listing of the Company. A further announcement will be made as appropriate. There can be no certainty that a transaction with Julian Dunkerton will be agreed.

This is a statement to which Rule 2.8 of the Code applies.

For the purposes of Note 2 on Rule 2.8 of the Code, Julian Dunkerton and any person(s) acting in concert with him reserve the right to make or participate in an offer for Superdry (and/or take any other actions which would otherwise be restricted under Rule 2.8 of the Code) within the next six months following the date of this announcement in the following circumstances:

 

(i) with the agreement of the Transaction Committee;

 

(ii) following the announcement of a firm intention to make an offer for Superdry by or on behalf of a third party;

 

(iii) following the announcement by Superdry of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Takeover Code) (excluding a Rule 9 waiver proposal by Julian Dunkerton) or a reverse takeover (as defined in the Code); or

 

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

Enquiries:

N. M. Rothschild & Sons Limited (Financial Adviser to Julian Dunkerton)

John Byrne

Charles Fenwick

+44 (0)121 600 5252

Important notice related to Financial Adviser

N. M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Julian Dunkerton and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Julian Dunkerton for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPEAKDPAFELEFA
Date   Source Headline
19th Dec 20199:51 amRNSDirector/PDMR Shareholding
16th Dec 201911:13 amRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSHalf-year Report
29th Nov 20199:51 amRNSTotal Voting Rights
15th Nov 201911:00 amRNSDirector/PDMR Shareholding
14th Nov 201910:45 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSPre-Close Trading Statement
31st Oct 201910:26 amRNSTotal Voting Rights
28th Oct 201911:32 amRNSDirector Declaration
18th Oct 20199:02 amRNSHolding(s) in Company
15th Oct 20199:37 amRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSStatement re Chief Executive Officer
30th Sep 20199:10 amRNSTotal Voting Rights
25th Sep 201911:15 amRNSDirector/PDMR Shareholding
25th Sep 201911:14 amRNSDirector/PDMR Shareholding
24th Sep 201910:10 amRNSDirector/PDMR Shareholding
24th Sep 20199:41 amRNSHolding(s) in Company
23rd Sep 20199:09 amRNSBlock listing Interim Review
16th Sep 201911:03 amRNSDirector/PDMR Shareholding
11th Sep 20191:17 pmRNSResult of AGM
30th Aug 201911:34 amRNSTotal Voting Rights
16th Aug 20199:54 amRNSDirector Declaration
16th Aug 20199:43 amRNSDirector/PDMR Shareholding
15th Aug 20199:33 amRNSDirector/PDMR Shareholding
13th Aug 201911:07 amRNSStatement re Chief Financial Officer
13th Aug 20199:07 amRNSStatement re Appointment of Corporate Broker
9th Aug 20199:52 amRNSAnnual Report and Notice of AGM
7th Aug 201910:27 amRNSDirector/PDMR Shareholding
31st Jul 201911:16 amRNSTotal Voting Rights
26th Jul 20197:00 amRNSNon-Executive Director Appointments
17th Jul 20199:59 amRNSHolding(s) in Company
16th Jul 20191:23 pmRNSDirector/PDMR Shareholding
15th Jul 20193:51 pmRNSDirector/PDMR Shareholding
10th Jul 201912:25 pmRNSFinal Dividend Record Date Correction
10th Jul 20197:00 amRNSFinal Results
4th Jul 20197:00 amRNSDirectorate Change
28th Jun 201911:10 amRNSTotal Voting Rights
27th Jun 20197:00 amRNSNotice of Preliminary Results
14th Jun 20197:59 amRNSDirector/PDMR Shareholding
4th Jun 201912:27 pmRNSDirector Declaration
3rd Jun 201912:26 pmRNSDirector/PDMR Shareholding
31st May 20199:30 amRNSTotal Voting Rights
22nd May 20197:00 amRNSSuperdry - Interim Chief Financial Officer
14th May 201911:24 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSPre-Close Trading Statement
30th Apr 201912:28 pmRNSTotal Voting Rights
17th Apr 201910:39 amRNSAppointment of Corporate Broker
16th Apr 20192:05 pmRNSDirector/PDMR Shareholding
11th Apr 20199:57 amRNSHolding(s) in Company
11th Apr 20199:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.